Comparative study of latanoprost (0.005%) and bimatoprost (0.03%) in primary open angle glaucoma.

IF 0.3 Q4 OPHTHALMOLOGY Nepalese Journal of Ophthalmology Pub Date : 2022-07-01 DOI:10.3126/nepjoph.v14i2.43026
Neyaz Kausar, Kamala Thapa
{"title":"Comparative study of latanoprost (0.005%) and bimatoprost (0.03%) in primary open angle glaucoma.","authors":"Neyaz Kausar,&nbsp;Kamala Thapa","doi":"10.3126/nepjoph.v14i2.43026","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Glaucoma can cause vision loss by damaging the optic nerve and increased intraocular pressure is one of the primary risk factors.</p><p><strong>Materials and methods: </strong>This was a hospital based, prospective, comparative, single masked (observer masked) study conducted on patients attending glaucoma department of Nepal Eye Hospital within a period of 1 year from February 2020 to January 2021. The sample size was 50. Specially designed proforma was used to collect the patient. Patients falling are divided in group A and group B randomly, patients using latanoprost were placed in group A and patients using bimatoprost were placed in group B. The examination procedure included history taking, Snellen visual acuity, refraction, gonioscopy, IOP measurement, slit lamp biomicroscopy and fundoscopy with 90 diopter lens.</p><p><strong>Results: </strong>Among fifty patients 33 (66%) were males and 17 (34 %) were females, 35 (70%) belonged to urban and 15 (30%) from rural population. Maximum number of patients were in the age group of 16-30 years i.e. 15 (30%), second highest group was 61-75 years of age group i.e. 14 (28%) , 11 i.e. 22% of patients were of 46-60 years of age group. Nine (18%) of patients were 31-45 years of age group and 1 i.e. 2% was above 75 years of age. Twenty percent presented with hypertension, 14 % with diabetes mellitus and 66 % with no systemic history. Ten percent had family history of glaucoma and 90% patients had no family history . Twenty-eight percent of patients had a family history of smoking and 72 % had no history. The mean IOP of group A (0.005% latanoprost) patients initially before the start of the treatment was 27.16 mm Hg, at sixth month IOP was 17.24 mm Hg, mean difference was 9.92 mm Hg and p value was < 0.001. The mean IOP of group B (0.03% bimatoprost) patients initially before the start of the treatment was 26.88 mm Hg , at the sixth month the IOP was 15.88 mm Hg , and the mean difference was 11.00 mm Hg and p value was < 0.001. There was a significant difference in IOP at first visit and 6 months in both groups, p<0.001. (The t-test is used.) However, the mean difference of group B, 11.00, is greater than group A, 9.92.</p><p><strong>Conclusion: </strong>Male gender, increasing age, urban population, hypertension, diabetes mellitus, and high intraocular pressure were the most prevalent risk factors. The most important factor is early detection of signs and symptoms and measurement of diurnal intraocular pressure.</p>","PeriodicalId":44759,"journal":{"name":"Nepalese Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/nepjoph.v14i2.43026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Glaucoma can cause vision loss by damaging the optic nerve and increased intraocular pressure is one of the primary risk factors.

Materials and methods: This was a hospital based, prospective, comparative, single masked (observer masked) study conducted on patients attending glaucoma department of Nepal Eye Hospital within a period of 1 year from February 2020 to January 2021. The sample size was 50. Specially designed proforma was used to collect the patient. Patients falling are divided in group A and group B randomly, patients using latanoprost were placed in group A and patients using bimatoprost were placed in group B. The examination procedure included history taking, Snellen visual acuity, refraction, gonioscopy, IOP measurement, slit lamp biomicroscopy and fundoscopy with 90 diopter lens.

Results: Among fifty patients 33 (66%) were males and 17 (34 %) were females, 35 (70%) belonged to urban and 15 (30%) from rural population. Maximum number of patients were in the age group of 16-30 years i.e. 15 (30%), second highest group was 61-75 years of age group i.e. 14 (28%) , 11 i.e. 22% of patients were of 46-60 years of age group. Nine (18%) of patients were 31-45 years of age group and 1 i.e. 2% was above 75 years of age. Twenty percent presented with hypertension, 14 % with diabetes mellitus and 66 % with no systemic history. Ten percent had family history of glaucoma and 90% patients had no family history . Twenty-eight percent of patients had a family history of smoking and 72 % had no history. The mean IOP of group A (0.005% latanoprost) patients initially before the start of the treatment was 27.16 mm Hg, at sixth month IOP was 17.24 mm Hg, mean difference was 9.92 mm Hg and p value was < 0.001. The mean IOP of group B (0.03% bimatoprost) patients initially before the start of the treatment was 26.88 mm Hg , at the sixth month the IOP was 15.88 mm Hg , and the mean difference was 11.00 mm Hg and p value was < 0.001. There was a significant difference in IOP at first visit and 6 months in both groups, p<0.001. (The t-test is used.) However, the mean difference of group B, 11.00, is greater than group A, 9.92.

Conclusion: Male gender, increasing age, urban population, hypertension, diabetes mellitus, and high intraocular pressure were the most prevalent risk factors. The most important factor is early detection of signs and symptoms and measurement of diurnal intraocular pressure.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
拉坦前列素(0.005%)与比马前列素(0.03%)治疗原发性开角型青光眼的比较研究。
青光眼可通过损害视神经导致视力丧失,眼压增高是主要危险因素之一。材料与方法:本研究是一项基于医院的前瞻性、比较性、单蒙面(观察者蒙面)研究,研究对象为尼泊尔眼科医院青光眼科的患者,时间为2020年2月至2021年1月,为期1年。样本量为50。采用特别设计的形式收集患者。将跌倒患者随机分为A组和B组,使用拉坦前列素的患者为A组,使用比马前列素的患者为B组。检查程序包括病史、Snellen视力、屈光、角镜检查、IOP测量、裂隙灯生物显微镜检查和90屈光度眼底镜检查。结果:50例患者中男性33例(66%),女性17例(34%),城镇35例(70%),农村15例(30%)。16 ~ 30岁患者最多15例(30%),其次为61 ~ 75岁患者14例(28%),46 ~ 60岁患者11例(22%)。31-45岁年龄组9例(18%),75岁以上1例(2%)。20%有高血压,14%有糖尿病,66%没有系统性病史。10%的患者有青光眼家族史,90%的患者无青光眼家族史。28%的患者有吸烟家族史,72%没有家族史。A组(0.005%拉坦前列素)患者治疗前平均IOP为27.16 mm Hg, 6个月时平均IOP为17.24 mm Hg,平均差异为9.92 mm Hg, p值< 0.001。B组(0.03%比马前列素)患者治疗前平均IOP为26.88 mm Hg, 6个月时平均IOP为15.88 mm Hg,平均差值为11.00 mm Hg, p值< 0.001。结论:男性、年龄增长、城市人口、高血压、糖尿病和高眼压是最常见的危险因素。最重要的因素是早期发现体征和症状,并测量每日眼压。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
27
审稿时长
12 weeks
期刊最新文献
Ocular Findings among the Patients of Renal Transplantation Radius-Maumenee Syndrome, A Rare Entity: A Case Report Developing Artificial Intelligence Model for Prediction of Diabetic Retinopathy and Delivering in a real-world Local Context: BP Eye Foundation’s Perspective A Case of Full Thickness Parafoveal Hole Associated with Chorio-Retinal Atrophy Hyperostotic Sphenoid Wing Meningioma with Proptosis: A Rare Case Report with Literature Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1